Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Xiaomei Ge
Introduction
Xiaomei Ge is a prominent inventor based in Emeryville, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work focuses on targeting CD22, a protein that plays a crucial role in certain types of cancers.
Latest Patents
Xiaomei Ge holds a patent titled "Constructs targeting CD22 and uses thereof." This patent describes antibodies, specifically single chain variable fragment (scFv) antibodies, and constructs that bind to the extracellular domain of CD22. The patent outlines methods for using these constructs in the therapeutic treatment of diseases characterized by CD22 expression, such as B-cell lymphomas and leukemias. She has 1 patent to her name.
Career Highlights
Xiaomei Ge is currently associated with Eureka Therapeutics, Inc., where she continues to advance her research in antibody development. Her innovative work has the potential to lead to new treatments for patients suffering from various cancers.
Collaborations
Throughout her career, Xiaomei has collaborated with notable colleagues, including Jun Cui and Pengbo Zhang. These collaborations have further enhanced her research and contributed to the advancement of therapeutic strategies in oncology.
Conclusion
Xiaomei Ge's contributions to the field of biotechnology, particularly through her patent on CD22-targeting constructs, highlight her role as an influential inventor. Her work promises to impact the treatment of B-cell lymphomas and leukemias significantly.